Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;26(7):2409-2424.
doi: 10.1007/s10461-022-03585-w. Epub 2022 Jan 22.

Utility and Impact of the Implementation of Same-Day, Self-administered Electronic Patient-Reported Outcomes Assessments in Routine HIV Care in two North American Clinics

Affiliations

Utility and Impact of the Implementation of Same-Day, Self-administered Electronic Patient-Reported Outcomes Assessments in Routine HIV Care in two North American Clinics

Duncan Short et al. AIDS Behav. 2022 Jul.

Abstract

The PROgress study assessed the value and feasibility of implementing web-based patient-reported outcomes assessments (PROs) within routine HIV care at two North American outpatient clinics. People with HIV (PWH) completed PROs on a tablet computer in clinic before their routine care visit. Data collection included PROs from 1632 unique PWH, 596 chart reviews, 200 patient questionnaires, and 16 provider/staff questionnaires. During an initial setup phase involving 200 patients, PRO results were not delivered to providers; for all subsequent patients, providers received PRO results before the consultation. Chart review demonstrated that delivery of PRO results to providers improved patient-provider communication and increased the number of complex health and behavioral issues identified, recorded, and acted on, including suicidal ideation (88% with vs 38% without PRO feedback) and anxiety (54% with vs 24% without PRO feedback). In post-visit questionnaires, PWH (82%) and providers (82%) indicated that the PRO added value to the visit.

Keywords: HIV care; Implementation science; Patient-reported outcomes; Quality of life; Suicidal ideation.

PubMed Disclaimer

Conflict of interest statement

DS is an employee of ViiV Healthcare and may own stock in GlaxoSmithKline. HC has received grants from ViiV Healthcare. SS has received grants from the Ontario HIV Treatment Network (OHTN). MR has received personal fees from Gilead, ViiV Healthcare, Janssen, and Merck for speaking engagements and/or consultancies. JBe has received personal fees from Merck, ViiV Healthcare, and Gilead for advisory board participation. BJ is an employee of Midway Immunology and Research Center, which was hired by Midway Specialty Care Center to oversee this project. RF, EF, JBa, AM, KG, JM, AK, VH, DK, and WL have nothing to disclose.

Figures

Fig. 1
Fig. 1
Example of patient-reported outcomes assessment provider feedback summary (based on a fictional patient). AUDIT-C Alcohol Use Disorders Identification Test for Consumption, DOB date of birth, HATQoL HIV/AIDS-Targeted Quality of Life, IPV intimate partner violence, MRN medical record number, PHQ-9 Patient Health Questionnaire 9
Fig. 2
Fig. 2
PROgress study design and participants. PWH people with HIV, PRO patient-reported outcomes assessment. aReasons for not initiating the PRO were language barriers (n = 68), felt not needed/useful (n = 22), literacy barriers (n = 21), not in mood (n = 13), vision problems (n = 11), perceived length (n = 10), cognitive problems (n = 7), too sick (n = 3), tired of it (n = 1), other reason (n = 6), and no reason given (n = 19). b2 participants did not complete the PRO for unknown reasons. cIncluding 1102 completed Acceptability E-scales. dQualitative analysis of one-on-one interviews is part of planned future work and is not described here. eSetup phase = without PRO feedback to providers; delivery phase = with PRO feedback to providers
Fig. 3
Fig. 3
Patient-reported outcomes assessment responses to HIV/AIDS-Targeted Quality of Life satisfaction with HIV medications questions
Fig. 4
Fig. 4
Results of structured surveys carried out during the delivery phase with A providers (N = 11) and B clinic staff (N = 5) to assess the perceived impact of PROs. PRO patient-reported outcomes assessment
Fig. 5
Fig. 5
Results of A PIPPI (N = 200) and B Acceptability E-scale (N = 1102) surveys to assess participants’ perceived impact and acceptability of PROs. aNumber of participants who responded to the question. bParticipants were asked to score the statements on a scale of 1 to 5. For panel A, 1 represented strong disagreement and 5 represented strong agreement. For panel B, 1 represented a low level of ease, satisfaction, and understanding and 5 represented a high level. *Mean scores significantly different between sites (P < 0.05, t test). MSCC Midway Specialty Care Center, PIPPI perceived impact of PROs on patient-provider interaction, PRO patient-reported outcomes assessment, SMH St Michael’s Hospital

References

    1. Grinsztejn B, De Castro N, Arnold V, et al. Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial. Lancet Infect Dis. 2014;14(6):459–467. doi: 10.1016/S1473-3099(14)70711-X. - DOI - PubMed
    1. Autenrieth CS, Beck EJ, Stelzle D, Mallouris C, Mahy M, Ghys P. Global and regional trends of people living with HIV aged 50 and over: estimates and projections for 2000–2020. PLoS ONE. 2018;13(11):e0207005. doi: 10.1371/journal.pone.0207005. - DOI - PMC - PubMed
    1. Harris TG, Rabkin M, El-Sadr WM. Achieving the fourth 90: healthy aging for people living with HIV. AIDS. 2018;32(12):1563–1569. doi: 10.1097/QAD.0000000000001870. - DOI - PMC - PubMed
    1. Kall M, Marcellin F, Harding R, Lazarus JV, Carrieri P. Patient-reported outcomes to enhance person-centred HIV care. Lancet HIV. 2020;7(1):e59–68. doi: 10.1016/S2352-3018(19)30345-5. - DOI - PubMed
    1. Lazarus JV, Safreed-Harmon K, Barton SE, et al. Beyond viral suppression of HIV—the new quality of life frontier. BMC Med. 2016;14(1):94. doi: 10.1186/s12916-016-0640-4. - DOI - PMC - PubMed